Avidity Partners Management LP Dyne Therapeutics, Inc. Transaction History
Avidity Partners Management LP
- $885 Million
- Q4 2024
A detailed history of Avidity Partners Management LP transactions in Dyne Therapeutics, Inc. stock. As of the latest transaction made, Avidity Partners Management LP holds 96,000 shares of DYN stock, worth $1.16 Million. This represents 0.26% of its overall portfolio holdings.
Number of Shares
96,000
Previous 165,000
41.82%
Holding current value
$1.16 Million
Previous $5.93 Million
61.85%
% of portfolio
0.26%
Previous 0.36%
Shares
2 transactions
Others Institutions Holding DYN
# of Institutions
213Shares Held
103MCall Options Held
135KPut Options Held
435K-
Atlas Venture Life Science Advisors, LLC8.02MShares$96.9 Million31.16% of portfolio
-
Black Rock Inc. New York, NY7.39MShares$89.2 Million0.01% of portfolio
-
Janus Henderson Group PLC London, X07.38MShares$89.1 Million0.09% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.7MShares$81 Million0.0% of portfolio
-
Ra Capital Management, L.P. Boston, MA6.38MShares$77.1 Million2.43% of portfolio
About Dyne Therapeutics, Inc.
- Ticker DYN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 51,765,400
- Market Cap $625M
- Description
- Dyne Therapeutics, Inc., a muscle disease company, operates as a biotechnology company that focuses on advancing therapeutics for genetically driven muscle diseases in the United States. It develops various programs for myotonic dystrophy type 1, duchenne muscular dystrophy, and facioscapulohumeral dystrophy, as well as rare skeletal muscle, and...